Cómo citar
1.
Gillis TP. Early detection os subclinical leprosy. Hansen. Int. [Internet]. 30 de junio de 1998 [citado 23 de noviembre de 2024];23(Especial):144-8. Disponible en: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35953
Resumen
.
Citas
1. CHO S.N., YANAGIHARA D.L., Hunter S.W., Gelber R.H. and P.J. Brennan. Serological specificity of phenolic glycolipid I from M. leprae and use in serodiagnosis of leprosy. Inf. Immun. 41:1077-1083, 1983.
2. deWIT M.Y.L., Faber W.R., S.R. Krieg, et al. Application of a polymerase chain reaction for the detection of M. leprae in skin tissue. J. Clin. MicrobioL 29:906-910, 1991.
3. GILLIS T.P., Tan E.V., Williams D.L., Balagon M.F., Cellona R.V. and G.P. Walsh. Detection of M. leprae in nasal secretions of household contacts of multibacillary patients. Int. J. Lepr. and Other Mycobact. Dis. (Abstr) 62:681, 1994.
4. GODALT., Mykelstad B., Samuel D. and B. Myrvang. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating M. leprae-reactive lymphocytes. Clin. Exp. Immunol. 9:821- 831, 1971.
5. HARTSKEERL R.A., deWit MYL and P.R. Klatser. Polymerase chain reaction for the detection of M. leprae. J. Gen. Microbiol. 135:2357-2364, 1989.
6. JAMET P., B. Ji and the Marchoux Chemotherapy Study Group. Relapse after long-term follow up of multibaclllary patients treated by WHO multidrug regimen. Int. J. Lepr. Other. Mycobac. Dis. 63:195-201, 1995.
7. JOB C.K., Jayakumar J., Williams D.L. and T.P. Gillis. Role of PCR in the diagnosis of early leprosy. Int. J. Lepr and Other Mycobact. In press, 1997.
8. KLATSER P.R., vanBeers S, Madjid B., Day R. and M.Y.L. deWit. Detection of M. leprae nasal carriers in populations for which leprosy is endemic. J. Clin. Microbiol 31:2947-2951, 1995.
9. MYRVANG B., Godal T., Ridley D.S., Froland S.S. and Y.K. Song. Immune responsiveness to M. leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin. Exp. Immuno/14:541-553, 1973.
10. PATTYN S.R., Ursi D., Leven M., Grillon S. and V. Raes. Detection of M. leprae by the polymerase chain reaction in nasal swabs of leprosy patients and their contacts. Int. J. Lepr. and Other Mycobact. 61:389-393, 1993.
11. SCOLLARD D.M., Williams D.L. and T.P. Gillis. PCR assay for the detection and identification of M. leprae in patients in the United States. Amer. J. Clin. Pathol. In press, 1997.
12. SINGH S., Jenner P.J., Narayan N.P., Ramu G., Colston M.J., Prasad H.K. and I Nath. Critical residues of the M. leprae LSR recombinant protein discriminate clinical activity in ENL reactions. Infect. and Immun. 62:5702-5705,
1994.
13. SINHA S, Sengupta U., Ramu G. and J. Ivanyi. A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to a MY2a determinant of M. leprae. Trans. R. Soc. Med. Hyg. 77:869-871, 1983.
14. THOMAS, B.M. and R. Mukherjee. Antineural antibodies in sera of leprosy patients. Clin. Immunol. and Immunopathol. 57:420-429, 1990.
15. WILLIAMS D.L., Gillis T.P., Booth R.J., Looker D. and J.D. Watson. The use of a specific DNA probe and PCR for detection of M. leprae. J. Infect. Dis. 162:193-200, 1990.
16. WILLIAMS D.L., Gillis T.P., Gelber R.H., Fallo P., Hill C. and S. Izumi. Detection of M. leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Mol. and Cell. Probes 6:401-410, 1992.
17. WOODS S.A. and S.T. Cole. A rapid method for the detection of potentially viable M. leprae in human biopsies: a novel application of PCR. FEMS Microbiol. Lett. 65:305-310, 1989.
18. World Health Organization. Action program for the elimination of leprosy: Status Report, 1996. Geneva:World Health Organization, 1997; WHO/LEP/96.5.
19. World Health Organization. Progress towards the elimination of leprosy as a public health problem. Part II. Wkly. Epidemiol. Rec. 70 (26):185-191, 1995.
20. World Health Organization Leprosy Unit. Risk of relapse in leprosy. Geneva: World Health Organization, 1995; WHO/ctd/lep/94.1.
2. deWIT M.Y.L., Faber W.R., S.R. Krieg, et al. Application of a polymerase chain reaction for the detection of M. leprae in skin tissue. J. Clin. MicrobioL 29:906-910, 1991.
3. GILLIS T.P., Tan E.V., Williams D.L., Balagon M.F., Cellona R.V. and G.P. Walsh. Detection of M. leprae in nasal secretions of household contacts of multibacillary patients. Int. J. Lepr. and Other Mycobact. Dis. (Abstr) 62:681, 1994.
4. GODALT., Mykelstad B., Samuel D. and B. Myrvang. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating M. leprae-reactive lymphocytes. Clin. Exp. Immunol. 9:821- 831, 1971.
5. HARTSKEERL R.A., deWit MYL and P.R. Klatser. Polymerase chain reaction for the detection of M. leprae. J. Gen. Microbiol. 135:2357-2364, 1989.
6. JAMET P., B. Ji and the Marchoux Chemotherapy Study Group. Relapse after long-term follow up of multibaclllary patients treated by WHO multidrug regimen. Int. J. Lepr. Other. Mycobac. Dis. 63:195-201, 1995.
7. JOB C.K., Jayakumar J., Williams D.L. and T.P. Gillis. Role of PCR in the diagnosis of early leprosy. Int. J. Lepr and Other Mycobact. In press, 1997.
8. KLATSER P.R., vanBeers S, Madjid B., Day R. and M.Y.L. deWit. Detection of M. leprae nasal carriers in populations for which leprosy is endemic. J. Clin. Microbiol 31:2947-2951, 1995.
9. MYRVANG B., Godal T., Ridley D.S., Froland S.S. and Y.K. Song. Immune responsiveness to M. leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin. Exp. Immuno/14:541-553, 1973.
10. PATTYN S.R., Ursi D., Leven M., Grillon S. and V. Raes. Detection of M. leprae by the polymerase chain reaction in nasal swabs of leprosy patients and their contacts. Int. J. Lepr. and Other Mycobact. 61:389-393, 1993.
11. SCOLLARD D.M., Williams D.L. and T.P. Gillis. PCR assay for the detection and identification of M. leprae in patients in the United States. Amer. J. Clin. Pathol. In press, 1997.
12. SINGH S., Jenner P.J., Narayan N.P., Ramu G., Colston M.J., Prasad H.K. and I Nath. Critical residues of the M. leprae LSR recombinant protein discriminate clinical activity in ENL reactions. Infect. and Immun. 62:5702-5705,
1994.
13. SINHA S, Sengupta U., Ramu G. and J. Ivanyi. A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to a MY2a determinant of M. leprae. Trans. R. Soc. Med. Hyg. 77:869-871, 1983.
14. THOMAS, B.M. and R. Mukherjee. Antineural antibodies in sera of leprosy patients. Clin. Immunol. and Immunopathol. 57:420-429, 1990.
15. WILLIAMS D.L., Gillis T.P., Booth R.J., Looker D. and J.D. Watson. The use of a specific DNA probe and PCR for detection of M. leprae. J. Infect. Dis. 162:193-200, 1990.
16. WILLIAMS D.L., Gillis T.P., Gelber R.H., Fallo P., Hill C. and S. Izumi. Detection of M. leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Mol. and Cell. Probes 6:401-410, 1992.
17. WOODS S.A. and S.T. Cole. A rapid method for the detection of potentially viable M. leprae in human biopsies: a novel application of PCR. FEMS Microbiol. Lett. 65:305-310, 1989.
18. World Health Organization. Action program for the elimination of leprosy: Status Report, 1996. Geneva:World Health Organization, 1997; WHO/LEP/96.5.
19. World Health Organization. Progress towards the elimination of leprosy as a public health problem. Part II. Wkly. Epidemiol. Rec. 70 (26):185-191, 1995.
20. World Health Organization Leprosy Unit. Risk of relapse in leprosy. Geneva: World Health Organization, 1995; WHO/ctd/lep/94.1.
Esta revista tiene la licencia Creative Commons Attribution 4.0 International License.
Descargas
Los datos de descargas todavía no están disponibles.
